Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950134-05-006254
Filing Date
2005-03-29
Accepted
2005-03-29 17:19:08
Documents
7
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K f06815e10vk.htm 10-K 846668
2 EXHIBIT 10.13 f06815exv10w13.htm EX-10.13 95633
3 EXHIBIT 23.1 f06815exv23w1.htm EX-23.1 1592
4 EXHIBIT 31.1 f06815exv31w1.htm EX-31.1 7640
5 EXHIBIT 31.2 f06815exv31w2.htm EX-31.2 7560
6 EXHIBIT 32.1 f06815exv32w1.htm EX-32.1 3249
7 EXHIBIT 32.2 f06815exv32w2.htm EX-32.2 3032
  Complete submission text file 0000950134-05-006254.txt   967417
Mailing Address
Business Address 275 MIDDLEFIELD ROAD SUITE A MENLO PARK CA 94025
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

EIN.: 770487658
Type: 10-K | Act: 34 | File No.: 000-50679 | Film No.: 05710535
SIC: 2834 Pharmaceutical Preparations